These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22766083)

  • 1. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
    Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
    Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
    Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
    JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors associated with development of severe-complicated Clostridium difficile infection.
    Shivashankar R; Khanna S; Kammer PP; Harmsen WS; Zinsmeister AR; Baddour LM; Pardi DS
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1466-71. PubMed ID: 23702192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
    Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
    Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in community-acquired Clostridium difficile infection.
    Khanna S; Pardi DS; Aronson SL; Kammer PP; Baddour LM
    Aliment Pharmacol Ther; 2012 Mar; 35(5):613-8. PubMed ID: 22229532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to Gastric Acid-Suppression Therapy Is Associated With Health Care- and Community-Associated Clostridium difficile Infection in Children.
    Jimenez J; Drees M; Loveridge-Lenza B; Eppes S; delRosario F
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):208-11. PubMed ID: 25806678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Clostridium difficile infections with acid suppression medications in children.
    Nylund CM; Eide M; Gorman GH
    J Pediatr; 2014 Nov; 165(5):979-84.e1. PubMed ID: 25112692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of community-acquired Clostridium difficile infection: a population-based study.
    Khanna S; Pardi DS; Aronson SL; Kammer PP; Orenstein R; St Sauver JL; Harmsen WS; Zinsmeister AR
    Am J Gastroenterol; 2012 Jan; 107(1):89-95. PubMed ID: 22108454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complicated Clostridium difficile colitis in children with cystic fibrosis: association with gastric acid suppression?
    Com G; Cetin N; O'Brien CE
    J Cyst Fibros; 2014 Jan; 13(1):37-42. PubMed ID: 23993432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias.
    Novack L; Kogan S; Gimpelevich L; Howell M; Borer A; Kelly CP; Leffler DA; Novack V
    PLoS One; 2014; 9(10):e110790. PubMed ID: 25343667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients.
    Brown KE; Knoderer CA; Nichols KR; Crumby AS
    Clin Pediatr (Phila); 2015 Oct; 54(11):1102-6. PubMed ID: 25644650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
    Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
    Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does PPI therapy predispose to Clostridium difficile infection?
    Pant C; Madonia P; Minocha A
    Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis.
    Mehta P; Nahass RG; Brunetti L
    Clin Infect Dis; 2021 Jul; 73(1):e62-e68. PubMed ID: 32386313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of Clostridium difficile infection in children: a population-based study.
    Khanna S; Baddour LM; Huskins WC; Kammer PP; Faubion WA; Zinsmeister AR; Harmsen WS; Pardi DS
    Clin Infect Dis; 2013 May; 56(10):1401-6. PubMed ID: 23408679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection in the community: are proton pump inhibitors to blame?
    Freedberg DE; Abrams JA
    World J Gastroenterol; 2013 Oct; 19(40):6710-3. PubMed ID: 24187445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.
    Kuntz JL; Chrischilles EA; Pendergast JF; Herwaldt LA; Polgreen PM
    BMC Infect Dis; 2011 Jul; 11():194. PubMed ID: 21762504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.